Nycomed US Inc

Prolong Pharmaceuticals, LLC, based in South Plainfield, NJ, is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for complex diseases, including ischemia, hypoxia within stroke, sickle cell disease, and cystic fibrosis. With a leadership team experienced in biotechnology and a pioneering approach to PEGylation, Prolong aims to meet critical unmet medical needs through its cutting-edge biopharma solutions. The company's flagship product, PP-007 Sanguinate, employs a novel PEGylated technology to restore homeostasis by delivering oxygen to hypoxic tissues and facilitating improved perfusion while reducing inflammation. Prolong Pharmaceuticals is committed to advancing healthcare through groundbreaking therapies targeting severe and life-threatening conditions, with a strong focus on addressing the global health issue of stroke. Generated from the website

Astellas Pharma US in Whitestone is dedicated to bringing brighter futures to patients, physicians, communities, and employees. As a new kind of pharmaceutical company, they prioritize improving the well-being of all stakeholders. With a focus on innovation and patient-centric care, Astellas Pharma US is committed to making a positive impact in the healthcare industry. Their mission is to provide cutting-edge solutions that enhance the lives of those they serve. Generated from their website's infomation